These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

947 related items for PubMed ID: 8667614

  • 1. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, Brown LF.
    Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
    [Abstract] [Full Text] [Related]

  • 2. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
    Guidi AJ, Abu-Jawdeh G, Tognazzi K, Dvorak HF, Brown LF.
    Cancer; 1996 Aug 01; 78(3):454-60. PubMed ID: 8697391
    [Abstract] [Full Text] [Related]

  • 3. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.
    Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF.
    Cancer Res; 1993 Oct 01; 53(19):4727-35. PubMed ID: 8402650
    [Abstract] [Full Text] [Related]

  • 4. Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.
    Brown LF, Detmar M, Tognazzi K, Abu-Jawdeh G, Iruela-Arispe ML.
    Lab Invest; 1997 Feb 01; 76(2):245-55. PubMed ID: 9042161
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.
    Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, Manseau EJ, Dvorak HF, Van de Water L.
    J Immunol; 1995 Mar 15; 154(6):2801-7. PubMed ID: 7876550
    [Abstract] [Full Text] [Related]

  • 6. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 15; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

  • 7. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.
    Couffinhal T, Kearney M, Witzenbichler B, Chen D, Murohara T, Losordo DW, Symes J, Isner JM.
    Am J Pathol; 1997 May 15; 150(5):1673-85. PubMed ID: 9137092
    [Abstract] [Full Text] [Related]

  • 8. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF, Guidi AJ, Schnitt SJ, Van De Water L, Iruela-Arispe ML, Yeo TK, Tognazzi K, Dvorak HF.
    Clin Cancer Res; 1999 May 15; 5(5):1041-56. PubMed ID: 10353737
    [Abstract] [Full Text] [Related]

  • 9. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL.
    Cancer Res; 1996 Dec 01; 56(23):5391-6. PubMed ID: 8968091
    [Abstract] [Full Text] [Related]

  • 10. Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma.
    Hashimoto M, Ohsawa M, Ohnishi A, Naka N, Hirota S, Kitamura Y, Aozasa K.
    Lab Invest; 1995 Dec 01; 73(6):859-63. PubMed ID: 8558848
    [Abstract] [Full Text] [Related]

  • 11. Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia.
    Denhart BC, Guidi AJ, Tognazzi K, Dvorak HF, Brown LF.
    Lab Invest; 1997 Dec 01; 77(6):659-64. PubMed ID: 9426404
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
    Barleon B, Siemeister G, Martiny-Baron G, Weindel K, Herzog C, Marmé D.
    Cancer Res; 1997 Dec 01; 57(23):5421-5. PubMed ID: 9393770
    [Abstract] [Full Text] [Related]

  • 13. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.
    Takagi H, King GL, Ferrara N, Aiello LP.
    Invest Ophthalmol Vis Sci; 1996 Jun 01; 37(7):1311-21. PubMed ID: 8641834
    [Abstract] [Full Text] [Related]

  • 14. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.
    Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, Carbone M, Watanabe Y, Pass HI.
    Br J Cancer; 1999 Sep 01; 81(1):54-61. PubMed ID: 10487612
    [Abstract] [Full Text] [Related]

  • 15. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G, Zhao M, Xu M, Yang Y, Wang M, Yang C.
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb 01; 25(2):89-93. PubMed ID: 11953105
    [Abstract] [Full Text] [Related]

  • 16. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
    Fine BA, Valente PT, Feinstein GI, Dey T.
    Gynecol Oncol; 2000 Jan 01; 76(1):33-9. PubMed ID: 10620438
    [Abstract] [Full Text] [Related]

  • 17. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
    Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR, Smith SK.
    J Natl Cancer Inst; 1995 Apr 05; 87(7):506-16. PubMed ID: 7707437
    [Abstract] [Full Text] [Related]

  • 18. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.
    Brown LF, Tognazzi K, Dvorak HF, Harrist TJ.
    Am J Pathol; 1996 Apr 05; 148(4):1065-74. PubMed ID: 8644848
    [Abstract] [Full Text] [Related]

  • 19. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.
    Bellamy WT, Richter L, Frutiger Y, Grogan TM.
    Cancer Res; 1999 Feb 01; 59(3):728-33. PubMed ID: 9973224
    [Abstract] [Full Text] [Related]

  • 20. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
    Breier G, Clauss M, Risau W.
    Dev Dyn; 1995 Nov 01; 204(3):228-39. PubMed ID: 8573716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.